Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
Tuberculosis (TB) is a chronic infection of global-health concern because of its high incidence, costly medical treatment, drug resistance and risk of co-infections. Anti-TB treatment involves a combination of drugs with high degree of liver toxicity, leading to drug-induced liver injury in 2–2...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioExcel Publishing Ltd
2023-01-01
|
| Col·lecció: | Drugs in Context |
| Matèries: | |
| Accés en línia: | https://www.drugsincontext.com/hepatoprotective-effects-of-silymarin-in-management-of-liver-injury-caused-by-tuberculosis-treatment |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|